CLINICAL_TRIALS
trial_result
· 2023-03-02
Clinical Trial Update: A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricaemia [Phase 2]
Summary
Phase 2 trial updating verinurad and allopurinol in chronic kidney disease with hyperuricemia; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Chronic Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2023-03-02